Booster

She told citizens to answer phone calls from government employees and answer questions regarding personal health information.

The FDA has "repeatedly stated that effectiveness against transmission remains unproven," the trio write, noting that the agency’s website maintains: "the scientific community does not yet know if Comirnaty will reduce such transmission."

“We just can’t allow corporate PR and product defense to pass as science anymore,” said U.S. Right to Know Executive Director Gary Ruskin.

Only 1 in 5 (20.5%) of U.S. adults had received a bivalent booster dose as of May 10, 2023.

"The conventional SARS-CoV-2 vaccine’s ability to provide immunological protection may be significantly impacted by over-vaccination. If this happens, either newly diagnosed COVID-19 cases or people who have already contracted the virus again may have a more severe case of the illness. This concept was proposed after seeing tolerance of both the humoral and cellular immune responses to prolonged booster immunization doses."

In a turn of events characterized by profound irony, an outbreak of the SARS-CoV-2 virus, which causes COVID-19, occurred at the 2023 Epidemic Intelligence Service (EIS) Conference hosted by the U.S. Centers for Disease Control and Prevention (CDC) itself.

Raising questions about the vaccine's advertised ability to protect against the disease.

Research shows that "the duration of protection after breakthrough infection was longer than after the third/booster vaccination."

One of the potentially serious side effects of COVID-19 vaccination is acute ischemic stroke, according to a publication in Journal of the Neurological Sciences.

However, a recent U.K. community-based population study found that those who have previously been infected with SARS-CoV-2, which causes COVID-19, demonstrate a lower rate of new Omicron BA.4/BA.5 infections compared to those who were vaccinated.